Jim Simons Tonix Pharmaceuticals Holding Corp. Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.46 - $1.3 $6,532 - $18,460
14,200 Added 1.18%
1,222,424 $723,000
Q4 2022

Feb 13, 2023
SELL
$0.29 - $0.57 $194,564 - $382,420
-670,913 Reduced 35.7%
1,208,224 $471,000
Q3 2022

Nov 14, 2022
BUY
$0.53 - $1.9 $655,086 - $2.35 Million
1,236,013 Added 192.19%
1,879,137 $1 Million
Q2 2022

Aug 12, 2022
BUY
$1.58 - $7.36 $1.02 Million - $4.73 Million
643,124 New
643,124 $1.02 Million

About Tonix Pharmaceuticals Holding Corp.

TNXP Quotes by TradingView
  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.81M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email